Allergan — Biomedical Watch V2

Traitements2programmes

Essais5liés

Publications1liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
PREDICT — Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®This study will prospectively assess long term heath related quality of life in chronic migraine patients currently being treated with OnabotulinumtoxinA for injection (BOTOX®) as standard of care.	Migraine	À vérifier	À vérifier	Canada	À vérifier
PREDICT — Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®This study will prospectively assess long term heath related quality of life in chronic migraine patients currently being treated with OnabotulinumtoxinA for injection (BOTOX®) as standard of care.	Migraine	À vérifier	À vérifier	Canada	À vérifier

Essais cliniques

5

Molécule	Indication / population	Phase	NCT	Titre	Statut
Atogepant	Migraine	Phase 3	NCT03777059	12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine	COMPLETED
Atogepant	Migraine	Phase 3	NCT03939312	Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine	COMPLETED
Atogepant 60 mg	Migraine	Phase 3	NCT04740827	ELEVATE — Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.	COMPLETED
PREDICT — Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®	Migraine	À vérifier	NCT02502123	PREDICT — Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®	COMPLETED
Botulinum toxin type A	Migraine	Phase 4	NCT02147561	A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine	COMPLETED

Publications

1

Molécule	Indication / population	Titre	Journal	Date
PREDICT — Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®		Response to BotulinumtoxinA in a migraine cohort with multiple comorbidities and widespread pain.	Regional anesthesia and pain medicine